Personal information

Emails & domains

Verified email addresses

Verified email domains

Countries

New Zealand, Ireland

Activities

Collapse all

Employment (3)

University of Auckland: Auckland, NZ

2024-05-01 to 2024-10-31 | Research Fellow (Faculty of Science)
Employment
Source: Self-asserted source
Fearghal Walsh

University of Auckland: Auckland, NZ

2023-02 to 2023-06 | CHEM110 Laboratory Coordinator (School of Chemical Sciences)
Employment
Source: Self-asserted source
Fearghal Walsh

University of Auckland: Auckland, NZ

2019-03 to 2022-11 | Graduate Teaching Assistant (School of Chemical Sciences)
Employment
Source: Self-asserted source
Fearghal Walsh

Education and qualifications (2)

The University of Auckland: Auckland, Auckland, NZ

2018-07-01 to 2023-08-31 | Doctorate of Philosophy in Chemistry (School of Chemical Sciences)
Education
Source: Self-asserted source
Fearghal Walsh

University College Cork: Cork, IE

2012-09 to 2016-05 | Bachelor of Science Chemistry (Honours) (School of Chemistry)
Education
Source: Self-asserted source
Fearghal Walsh

Professional activities (4)

Society of Biological Inorganic Chemistry: Adelaide, AU

2023-07-16 | Travel award to attend the 20th Internation Conference on Biological Inorganic Chemistry
Distinction
Source: Self-asserted source
Fearghal Walsh

University of Auckland: Auckland, NZ

2023-06-18 | Certificate of Tutoring in Science (School of Chemical Sciences)
Distinction
Source: Self-asserted source
Fearghal Walsh

The University of Auckland: Auckland, Auckland, NZ

2020-11-03 | Second place postgrad poster competition at Innovation Showcase 2020 (School of Chemical Sciences)
Distinction
Source: Self-asserted source
Fearghal Walsh

The University of Auckland: Auckland, Auckland, NZ

2019-09-18 | Third place people's choice award at the Postgraduate Research Showcase 2019 (School of Chemical Sciences)
Distinction
Source: Self-asserted source
Fearghal Walsh

Works (4)

Anti-Proliferative, Anti-Angiogenic and Safety Profiles of Novel HDAC Inhibitors for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Pharmaceuticals
2021-10 | Journal article | Author
DOI: 10.3390/ph14101020
Contributors: Zohaib Rana; Sarah Diermeier; Fearghal Walsh; Muhammad Hanif; Christian Hartinger; Rhonda J. Rosengren
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands

Coordination Chemistry Reviews
2021-10 | Journal article
DOI: 10.1016/j.ccr.2021.213950
Contributors: William D.J. Tremlett; David M. Goodman; Tasha R. Steel; Saawan Kumar; Anna Wieczorek-Błauż; Fearghal P. Walsh; Matthew P. Sullivan; Muhammad Hanif; Christian G. Hartinger
Source: check_circle
Crossref

Monodentately-coordinated bioactive moieties in multimodal half-sandwich organoruthenium anticancer agents

Coordination Chemistry Reviews
2021-07 | Journal article
DOI: 10.1016/j.ccr.2021.213890
Contributors: Tasha R. Steel; Fearghal Walsh; Anna Wieczorek-Błauż; Muhammad Hanif; Christian G. Hartinger
Source: check_circle
Crossref

High Antiproliferative Activity of Hydroxythiopyridones over Hydroxypyridones and Their Organoruthenium Complexes

Biomedicines
2021-01-27 | Journal article
DOI: 10.3390/biomedicines9020123
Contributors: Md. Salman Shakil; Shahida Parveen; Zohaib Rana; Fearghal Walsh; Sanam Movassaghi; Tilo Söhnel; Mayur Azam; Muhammad Ashraf Shaheen; Stephen M. F. Jamieson; Muhammad Hanif et al.
Source: check_circle
Crossref
How many people are using ORCID?